Unicycive Therapeutics Inc (UNCY)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $97.25M
Last updated: Nov 17, 2026 at 11:06 AM ET
Unicycive Therapeutics Inc (UNCY) Earnings: Report Dates and Results
Unicycive Therapeutics (UNCY) is expected to report earnings on Mar 29, 2027. In the quarter ended Sep 30, 2026, Unicycive Therapeutics reported EPS of -$0.39, below the -$0.33 estimate. It beat the EPS estimate in 5 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
UNCY has an expected report date of Mar 29, 2027.
Earnings History
Of the 22 quarters below that had an estimate, UNCY beat 8, missed 13 and matched 1. The widest gap in the table came in the quarter ended Dec 31, 2024, when EPS landed 373.52% above the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported |
|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.39 | -$0.33 | -$0.66 - -$0.23 | -18.18% | Miss | N/A | 9 | 1 up, 0 down | Nov 11, 2026 |
| Jun 30, 2026 | -$0.06 | -$0.34 | -$0.37 - -$0.30 | +82.35% | Beat | N/A | 7 | 2 up, 1 down | Aug 12, 2026 |
| Mar 31, 2026 | -$0.54 | -$0.48 | -$1.23 - -$0.29 | -11.47% | Miss | N/A | 10 | 5 up, 1 down | May 12, 2026 |
| Dec 31, 2025 | -$0.82 | -$0.46 | -$0.79 - -$0.31 | -78.26% | Miss | -428.0% | 8 | 0 up, 0 down | Mar 30, 2026 |
| Sep 30, 2025 | -$0.33 | -$0.53 | -$0.74 - -$0.35 | +37.74% | Beat | N/A | 8 | 2 up, 0 down | Nov 12, 2025 |
| Jun 30, 2025 | -$0.52 | -$0.70 | -$0.80 - -$0.50 | +25.71% | Beat | -134.7% | 7 | N/A | Aug 14, 2025 |
| Mar 31, 2025 | -$0.50 | -$0.62 | -$0.80 - -$0.30 | +19.35% | Beat | N/A | 5 | 1 up, 2 down | May 14, 2025 |
| Dec 31, 2024 | $0.25 | -$0.09 | -$0.09 - -$0.05 | +373.52% | Beat | N/A | 5 | 3 up, 0 down | Mar 27, 2025 |
| Sep 30, 2024 | -$0.50 | -$1.52 | -$2.80 - -$0.70 | +67.11% | Beat | N/A | 6 | 4 up, 2 down | Nov 12, 2024 |
| Jun 30, 2024 | $1.50 | -$1.92 | -$2.80 - -$0.60 | +178.13% | Beat | N/A | 6 | 0 up, 0 down | Aug 14, 2024 |
| Mar 31, 2024 | -$6.10 | -$1.55 | -$2.10 - -$0.90 | -293.55% | Miss | N/A | 4 | 1 up, 0 down | May 13, 2024 |
| Dec 31, 2023 | -$0.22 | -$0.17 | -$0.18 - -$0.13 | -29.41% | Miss | N/A | 4 | 0 up, 0 down | Mar 28, 2024 |
| Sep 30, 2023 | -$1.30 | -$1.30 | -$1.30 - -$1.10 | 0.00% | In line | N/A | 2 | 0 up, 0 down | Nov 14, 2023 |
| Jun 30, 2023 | -$2.90 | -$3.20 | -$4.40 - -$0.90 | +9.38% | Beat | N/A | 5 | 0 up, 0 down | Aug 14, 2023 |
| Mar 31, 2023 | -$9.70 | -$3.72 | -$4.10 - -$3.10 | -160.75% | Miss | N/A | 4 | 0 up, 0 down | May 16, 2023 |
| Dec 31, 2022 | -$0.35 | -$0.24 | -$0.38 - -$0.16 | -45.83% | Miss | N/A | 5 | 0 up, 0 down | Mar 31, 2023 |
| Sep 30, 2022 | -$3.70 | -$2.80 | -$4.50 - -$1.50 | -32.14% | Miss | N/A | 3 | 0 up, 0 down | Nov 14, 2022 |
| Jun 30, 2022 | -$2.40 | -$2.27 | N/A | -5.73% | Miss | N/A | N/A | 0 up, 0 down | Aug 15, 2022 |
| Mar 31, 2022 | -$2.40 | -$1.90 | -$2.00 - -$1.30 | -26.32% | Miss | N/A | 2 | 0 up, 0 down | May 12, 2022 |
| Dec 31, 2021 | -$0.24 | -$0.13 | -$0.16 - -$0.11 | -84.62% | Miss | N/A | 2 | N/A | Mar 31, 2022 |
| Sep 30, 2021 | -$3.70 | -$1.00 | -$1.10 - -$1.00 | -270.00% | Miss | N/A | 2 | 0 up, 0 down | Nov 11, 2021 |
| Jun 30, 2021 | -$1.30 | -$1.10 | -$1.10 - -$1.10 | -18.18% | Miss | N/A | 1 | N/A | Aug 16, 2021 |
| Mar 31, 2021 | -$0.07 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 21, 2021 |
| Sep 30, 2020 | -$0.06 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 2, 2020 |
| Jun 30, 2020 | -$0.03 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Sep 15, 2020 |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$2.17, after -$4.85 the year before. It was -$5.40 for the year ended Dec 31, 2021, the oldest of the 5 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$2.17 | N/A |
| Dec 31, 2024 | -$4.85 | N/A |
| Dec 31, 2023 | -$14.12 | N/A |
| Dec 31, 2022 | -$8.85 | N/A |
| Dec 31, 2021 | -$5.40 | N/A |
Frequently Asked Questions About UNCY
When is Unicycive Therapeutics's next earnings date?
Unicycive Therapeutics's next earnings report is expected for Mar 29, 2027.
Did UNCY beat earnings estimates last quarter?
No. Unicycive Therapeutics reported EPS of -$0.39 for the quarter ended Sep 30, 2026, below the -$0.33 estimate by 18.18%.
What EPS do analysts expect from UNCY next quarter?
The consensus EPS estimate for Unicycive Therapeutics for the quarter ending Dec 31, 2026 is -$0.34 from 11 analysts, with estimates from -$0.42 to -$0.26.
How often does UNCY beat earnings estimates?
Unicycive Therapeutics beat the EPS estimate in 5 of the last 8 quarters, with an average surprise of +53.85%.
UNCY pages: Overview, Earnings, Forecast, Financials, Competitors